相关实验视频

Updated: Feb 25, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

整合液体活检和突变特征,以推进精确的瘤学

Raquel Carrasco¹, Kristian Dreij²

¹Institute of Environmental Medicine, Karolinska Institutet, Solna, Sweden. raquel.carrasco.romo@ki.se.

NPJ precision oncology

|February 23, 2026

概括

精确瘤学在固体瘤中面临着挑战. 结合液体活检和突变特征,为纵向检测提供了一个框架,改善了癌症查,诊断和个性化治疗.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
分子诊断学分子诊断

背景情况:

精密瘤学旨在根据个体瘤遗传学量身定制癌症治疗方法.
固体瘤由于遗传异质性和缺乏可操作的点而存在挑战.
目前的方法与纵向监测瘤演变有所困难.

研究的目的:

审查液体活检和突变特征的整合.
为解决精密瘤学的局限性提出一个框架.
为突出癌症查,诊断和治疗方面的进展.

主要方法:

关于液体活检的当前文献的综述.
分析瘤发育中的突变特征.
讨论这些方法的综合潜力.

主要成果:

液体活检允许对瘤进行非侵入性的纵向监测.
突变特征为癌症的起源和演变提供了洞察力.
这种组合为精密瘤学提供了一个全面的方法.

结论:

结合液体活检和突变特征可以克服固体瘤精确瘤学的关键挑战.
这一框架提高了早期癌症检测和诊断准确度.
它有望改进个性化治疗策略,并推进癌症治疗.

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...